AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $72,000 | +148.3% | 11,139 | +52.0% | 0.00% | – |
| Q3 2019 | $29,000 | -19.4% | 7,326 | -1.0% | 0.00% | – |
| Q2 2019 | $36,000 | -41.0% | 7,400 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $61,000 | +13.0% | 7,400 | -25.4% | 0.00% | 0.0% |
| Q4 2018 | $54,000 | +1700.0% | 9,919 | +3206.3% | 0.00% | – |
| Q3 2018 | $3,000 | -57.1% | 300 | -54.3% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 657 | -1.2% | 0.00% | – |
| Q1 2018 | $6,000 | -40.0% | 665 | -0.2% | 0.00% | – |
| Q4 2017 | $10,000 | -23.1% | 666 | 0.0% | 0.00% | – |
| Q3 2017 | $13,000 | +85.7% | 666 | +25.0% | 0.00% | – |
| Q2 2017 | $7,000 | +250.0% | 533 | +96.7% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 271 | -5.6% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 287 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 287 | +51.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |